Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are hormonal contraceptives teratogenic?

L M Ambani, N J Joshi, R A Vaidya

    Fertility and Sterility
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In vitro macrophage activation: A technique for screening anti-inflammatory, immunomodulatory and anticancer activity of phytomolecules.

    Indian journal of experimental biology·2018
    Same author

    INTRAMUSCULAR 15(S)15 METHYL PGF<sub>2α</sub> FOR PREOPERATIVE CERVICAL DILATATION DURING FIRST TRIMESTER.

    Acta obstetricia et gynecologica Scandinavica·2017
    Same author

    STUDIES ON 15(S)15 METHYL PGF<sub>2α</sub> BY INTRAMUSCULAR ROUTE FOR SECOND TRIMESTER ABORTION (TWO HOURLY SCHEDULE).

    Acta obstetricia et gynecologica Scandinavica·2017
    Same author

    Observation of D+ → K(+)η(') and search for CP violation in D+ → π(+)η(') decays.

    Physical review letters·2011
    Same author

    Observation of X(3872)→J/ψγ and search for X(3872)→ψ'γ in B decays.

    Physical review letters·2011
    Same author

    Observation of transverse polarization asymmetries of charged pion pairs in e+e- annihilation near √s = 10.58 GeV.

    Physical review letters·2011

    Hormonal contraceptive use before pregnancy appears safe for offspring. However, using hormones during pregnancy may increase congenital malformations, particularly in susceptible fetuses. Avoid hormonal treatments for threatened abortions.

    Area of Science:

    • Reproductive Health
    • Teratology
    • Pharmacology

    Background:

    • Hormonal contraceptives are widely used by women of childbearing age.
    • Potential teratogenic effects of hormones during or before pregnancy require careful consideration.
    • Documenting a definitive link between hormonal exposure and adverse outcomes has been challenging.

    Purpose of the Study:

    • To evaluate the safety of hormonal contraceptive use concerning fetal development.
    • To assess the risks associated with hormonal administration prior to and during pregnancy.
    • To provide guidance on the appropriate use of hormonal agents in reproductive health.

    Main Methods:

    • Review of existing literature and reports on hormonal contraceptive use and pregnancy outcomes.

    Related Experiment Videos

  • Analysis of data regarding chromosomal aberrations and congenital malformations.
  • Evaluation of teratogenic potential based on hormonal exposure timing.

    • Main Results:

    • Hormonal use prior to pregnancy does not appear to increase chromosomal aberrations or congenital malformations.
    • Certain hormones used during pregnancy may elevate the risk of congenital malformations in genetically predisposed fetuses.
    • The safety of inadvertent hormonal contraceptive exposure in early pregnancy remains unresolved.

    Conclusions:

    • Hormonal contraceptives should not be used for threatened abortion treatment or as pregnancy tests.
    • Women should be informed about potential risks if hormonal pills are inadvertently taken during early pregnancy.
    • Further research is needed to fully elucidate risks of early pregnancy hormonal exposure.